← Evidence map

ArticleMolecular diagnosis & therapy2018

Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients.

Doaa Ali Abdelmonsif et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29094287